Charles Gaber1, Rafael Meza2,3, Julie J Ruterbusch4, Michele L Cote4,5. 1. Department of Epidemiology, University of Michigan School of Public Health, 1415 Washington Heights, Ann Arbor, MI, 48105, USA. 2. Department of Epidemiology, University of Michigan School of Public Health, 1415 Washington Heights, Ann Arbor, MI, 48105, USA. rmeza@umich.edu. 3. Department of Epidemiology, University of Michigan, 1415 Washington Heights SPH-II 5533, Ann Arbor, MI, 48109-2029, USA. rmeza@umich.edu. 4. Department of Oncology, Wayne State University School of Medicine, 4100 John R MM04EP, Detroit, MI, 48201, USA. 5. Karmanos Cancer Institute, Population Studies and Disparities Research Program, Detroit, MI, USA.
Abstract
OBJECTIVES: The aim of this study is to explore incidence and incidence-based mortality trends for endometrial cancer in the USA and project future incident cases, accounting for differences by race and histological subtype. METHODS: Data on age-adjusted and age-specific incidence and mortality rates of endometrial cancer were obtained from the Surveillance, Epidemiology, and End Results 18 registries. Trends in rates were analyzed using Joinpoint regression, and average annual percent change (AAPC) in recent years (2006-2011) was computed for histological subtypes by race. Age, histological, and race-specific rates were applied to US Census Bureau population census estimates to project new cases from 2015 to 2040, accounting for observed AAPC trends, which were progressively attenuated for the future years. RESULTS: The annual number of cases is projected to increase substantially from 2015 to 2040 across all racial groups. Considerable variation in incidence and mortality trends was observed both between and within racial groups when considering histology. CONCLUSIONS: As the US population undergoes demographic changes, incidence of endometrial cancer is projected to rise. The increase will occur in all racial groups, but larger increases will be seen in aggressive histology subtypes that disproportionately affect black women.
OBJECTIVES: The aim of this study is to explore incidence and incidence-based mortality trends for endometrial cancer in the USA and project future incident cases, accounting for differences by race and histological subtype. METHODS: Data on age-adjusted and age-specific incidence and mortality rates of endometrial cancer were obtained from the Surveillance, Epidemiology, and End Results 18 registries. Trends in rates were analyzed using Joinpoint regression, and average annual percent change (AAPC) in recent years (2006-2011) was computed for histological subtypes by race. Age, histological, and race-specific rates were applied to US Census Bureau population census estimates to project new cases from 2015 to 2040, accounting for observed AAPC trends, which were progressively attenuated for the future years. RESULTS: The annual number of cases is projected to increase substantially from 2015 to 2040 across all racial groups. Considerable variation in incidence and mortality trends was observed both between and within racial groups when considering histology. CONCLUSIONS: As the US population undergoes demographic changes, incidence of endometrial cancer is projected to rise. The increase will occur in all racial groups, but larger increases will be seen in aggressive histology subtypes that disproportionately affect black women.
Entities:
Keywords:
AAPC; Cancer disparities; Endometrial cancer; Incidence projections; Joinpoint regression
Authors: M Aamir Sheikh; Andrew D Althouse; Kyle E Freese; Sean Soisson; Robert P Edwards; Sharon Welburn; Paniti Sukumvanich; John Comerci; Joseph Kelley; Ronald E LaPorte; Faina Linkov Journal: Future Oncol Date: 2014-12 Impact factor: 3.404
Authors: Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian Journal: Cancer Res Date: 2014-06-01 Impact factor: 12.701
Authors: William M Burke; James Orr; Mario Leitao; Emery Salom; Paola Gehrig; Alexander B Olawaiye; Molly Brewer; Dave Boruta; Jeannine Villella; Jeanine Villella; Tom Herzog; Fadi Abu Shahin Journal: Gynecol Oncol Date: 2014-06-04 Impact factor: 5.482
Authors: Michele L Cote; Tala Alhajj; Julie J Ruterbusch; Leslie Bernstein; Louise A Brinton; William J Blot; Chu Chen; Margery Gass; Sarah Gaussoin; Brian Henderson; Eunjung Lee; Pamela L Horn-Ross; Laurence N Kolonel; Andrew Kaunitz; Xiaolin Liang; Wanda K Nicholson; Amy B Park; Stacey Petruzella; Timothy R Rebbeck; V Wendy Setiawan; Lisa B Signorello; Michael S Simon; Noel S Weiss; Nicolas Wentzensen; Hannah P Yang; Anne Zeleniuch-Jacquotte; Sara H Olson Journal: Cancer Causes Control Date: 2014-12-23 Impact factor: 2.506
Authors: G Larry Maxwell; Chunqiao Tian; John Risinger; Carol L Brown; G Scott Rose; J Tate Thigpen; Gini F Fleming; Holly H Gallion; Wendy R Brewster Journal: Cancer Date: 2006-11-01 Impact factor: 6.860
Authors: Benjamin D Smith; Grace L Smith; Arti Hurria; Gabriel N Hortobagyi; Thomas A Buchholz Journal: J Clin Oncol Date: 2009-04-29 Impact factor: 44.544
Authors: Jason D Wright; Thomas J Herzog; Jennifer Tsui; Cande V Ananth; Sharyn N Lewin; Yu-Shiang Lu; Alfred I Neugut; Dawn L Hershman Journal: Obstet Gynecol Date: 2013-08 Impact factor: 7.661
Authors: Megan A Clarke; Beverly J Long; Arena Del Mar Morillo; Marc Arbyn; Jamie N Bakkum-Gamez; Nicolas Wentzensen Journal: JAMA Intern Med Date: 2018-09-01 Impact factor: 21.873
Authors: Nicholas W Bateman; Pang-Ning Teng; Erica Hope; Brian L Hood; Julie Oliver; Wei Ao; Ming Zhou; Guisong Wang; Domenic Tommarello; Katlin Wilson; Tracy Litzy; Kelly A Conrads; Chad A Hamilton; Kathleen M Darcy; Yovanni Casablanca; George Larry Maxwell; Victoria Bae-Jump; Thomas P Conrads Journal: Cancer Med Date: 2019-12-06 Impact factor: 4.452
Authors: Anna Kimberly Miller; Jennifer Catherine Gordon; Jacqueline W Curtis; Jayakrishnan Ajayakumar; Fredrick R Schumacher; Stefanie Avril Journal: Int J Environ Res Public Health Date: 2022-07-15 Impact factor: 4.614
Authors: Simon M Manga; Yuanfan Ye; Jeff M Szychowski; Kathleen L Nulah; Calvin Ngalla; Kaitlyn Kincaid; Teresa K L Boitano; Alan T Tita; Isabel Scarinci; Warner K Huh; Zacharie Sando; Margaret I Liang Journal: Gynecol Oncol Rep Date: 2021-06-24
Authors: Jan Yvan Verbakel; Ruben Heremans; Laure Wynants; Elisabeth Epstein; Bavo De Cock; Maria Angela Pascual; Francesco Paolo Giuseppe Leone; Povilas Sladkevicius; Juan Luis Alcazar; Catherine Van Pachterbeke; Ligita Jokubkiene; Robert Fruscio; Tom Bourne; Ben Van Calster; Dirk Timmerman; Thierry Van den Bosch Journal: Int J Gynaecol Obstet Date: 2022-02-07 Impact factor: 4.447